Morgan Stanley
NMRD

Morgan Stanley’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Morgan Stanley’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-200
Closed -$44 – 8129
2023
Q4 		$44 Buy
200
+100
+100% +$24 ﹤0.01% 7687
2023
Q3 		$32 Hold
100
– – ﹤0.01% 7512
2023
Q2 		$93 Hold
100
– – ﹤0.01% 7503
2023
Q1 		$90 Hold
100
– – ﹤0.01% 7580
2022
Q4 		$172 Hold
100
– – ﹤0.01% 7657
2022
Q3 		$0 Hold
100
– – ﹤0.01% 7980
2022
Q2 		$0 Sell
100
-138
-58% -$442 ﹤0.01% 8085
2022
Q1 		$1K Buy
238
+70
+42% +$293 ﹤0.01% 7894
2021
Q4 		$1K Sell
168
-24,780
-99% -$133K ﹤0.01% 7909
2021
Q3 		$150K Sell
24,948
-25,365
-50% -$183K ﹤0.01% 6147
2021
Q2 		$521K Buy
50,313
+49,554
+6,529% +$473K ﹤0.01% 5501
2021
Q1 		$6K Sell
759
-4,720
-86% -$31.2K ﹤0.01% 7076
2020
Q4 		$21K Buy
5,479
+4,828
+742% +$18.6K ﹤0.01% 6427
2020
Q3 		$2K Sell
651
-1,427
-69% -$8.33K ﹤0.01% 6604
2020
Q2 		$19K Buy
+2,078
New +$14.8K ﹤0.01% 6026

Other funds holding NMRD

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Morgan Stanley's NMRD Position: Q1 2024 in Review

Morgan Stanley sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q1 2024, closing a stake of 200 shares — an estimated $44 sold.

Morgan Stanley first reported a position in NMRD in Q2 2020 and held it in 15 quarters. The position peaked at $521K in Q2 2021. 2 funds tracked by Wall St. Rank hold NMRD as of Q1 2024.

  • Morgan Stanley reported no remaining Nemaura Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Morgan Stanley sold 200 Nemaura Medical, Inc. Common Stock shares in Q1 2024, an estimated $44.
  • Morgan Stanley first reported a position in Nemaura Medical, Inc. Common Stock in Q2 2020 and held it in 15 quarters.
  • Morgan Stanley's Nemaura Medical, Inc. Common Stock position peaked at $521K in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q1 2024.

Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.